Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

NCT03389308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidermolysis Bullosa
Epidermolysis Bullosa Simplex

Interventions

DRUG: diacerein 1% ointment

Sponsor

Castle Creek Pharmaceuticals, LLC